Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.

Parikh, P M; Shah, S R; Shah, S C; Sheth, V; Patel, R A; Shah, K C; Jain, P K

Parikh, P M; Shah, S R; Shah, S C; Sheth, V; Patel, R A; Shah, K C; Jain, P K.

Indian J Cancer ; 1996 Mar; 33(1): 17-20

Artículo en Inglés | IMSEAR | ID: sea-50995

ABSTRACT

ABSTRACT

Ondansetron was used as an antiemetic along with dexamethasone during 16 cycles of highly or moderately ematogenic chemotherapy. There was major control in two cycles and complete control in the remaining 14. Side effects were minor and did not require discontinuation of the drug. This combination, therefore, appears to be safe and effective in preventing chemotherapy induced emesis.

Asunto(s)

Adulto; Antieméticos/efectos adversos; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Dexametasona/efectos adversos; Relación Dosis-Respuesta a Droga; Quimioterapia Combinada; Femenino; Humanos; Masculino; Persona de Mediana Edad; Ondansetrón/efectos adversos; Receptores de Serotonina/efectos de los fármacos; Receptores de Serotonina 5-HT3; Antagonistas de la Serotonina/efectos adversos; Vómitos/prevención & control

Texto completo

Imprimir

XML

Buscar en Google

Texto completo: Disponible Índice: IMSEAR (Asia Sudoriental) Asunto principal: Antagonistas de la Serotonina / Vómitos / Femenino / Humanos / Masculino / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Serotonina / Ondansetrón / Adulto Idioma: Inglés Revista: Indian J Cancer Año: 1996 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

Buscar en Google